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• Increased incidence with age in male general population & in male 
organ donors
• - < 50 years: 0.5%
- 50-59 years: 23%
- 60-69 years: 35%
- >70 years: 45%




• 2 case reports of prostate cancer transmission with organ
transplantation
- 1 LT was diagnosed 2 months after LT
- 1 case of  a heart recipient
Sanchez-Montes C et al, Am J Gastroenterol 2019
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• PSA dosing: no role in PK detection in deceased organ donors
• No role for active screening of potential donors (US, Rectal exam)
• Donor with past history of prostate K: Gleason’ score
• group 1 Gleason score £ 6 (3+3)
• group 2 Gleason score 7 (3+4)
• group 3 Gleason score 7 (4+3)
• group 4 Gleason score 8 (4+4, 3+5, 5+3)
• group 5 Gleason score ³ 9 (4+5, 5+4, 5+5)







• During surgical procurement, any enlarged (pelvic) lymph node
should be analysed by frozen section
• No recommendation for post-mortem histologic analysis of prostate
.
:
4.7: Renal cell adenocarcinoma
• No published case of RCC transmission with LT
• Cases of RCC transmission with kidney, heart and/or lung Tx
• Detection:
- donor US and/or CT
- during surgery (procurement and/or back-table): frozen section
• Donor with past history of RCC: whole body CT
.
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4.7: Renal cell adenocarcinoma
• 2018 Council of Europe guidelines
- RCC < 1 cm (stage T1a AJCC 8th edn) and nucleolar grade I/II (Fuhrman 
grade I/II) can be considered minimal-risk for transmission;
- RCC 1-4 cm (stage T1a AJCC 8th edn) and nucleolar grade I/II 
(Fuhrman grade I/II) are considered low-risk;
- RCC 4-7 cm (stage T1b AJCC 8th edn) and nucleolar grade I/II 
(Fuhrman grade I/II) are considered intermediate-risk;
- RCC > 7 cm (stage T2 AJCC 8th edn) and nucleolar grade I/II (Fuhrman 
grade I/II) or Fuhrman grade III-IV (any T) are considered high-risk;
- T3/T4 or N+ or M+: CI to procurement & transplantation
.
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THANK YOU !
